期刊文献+

复方玄驹胶囊联合他达拉非治疗腹型肥胖伴勃起功能障碍 被引量:5

Clinical Study of Compound Xuanju Capsule Combined with Tadalafi in the Treatment of Abdominal Obesity with Erectile Dysfunction
原文传递
导出
摘要 目的:探讨复方玄驹胶囊联合他达拉非治疗腹型肥胖伴勃起功能障碍的临床疗效。方法:筛选2016年8月-2017年1月我科门诊腹型肥胖伴勃起功能障碍的80例患者,分为2组。复方玄驹胶囊联合他达拉非治疗为观察组,单纯服用他达拉非治疗为对照组(n=40),均治疗4周后复诊。结果:两组患者治疗后IIEF-5评分及性交成功率(SEP-Q3)均较治疗前提高(P<0.05),观察组IIEF-5评分治疗前、后分别为(11.52±2.98)、(20.61±1.91)分,对照组IIEF-5评分治疗前、后分别为(11.28±3.56)、(17.32±2.02)分;对照组和观察组SEP-Q3治疗后总有效率分别为72.5%、90.0%,观察组患者疗效优于对照组,两组患者治疗期间均未出现严重不良反应。结论:采用复方玄驹胶囊联合他达拉非方案可有效改善腹型肥胖伴ED患者的IIEF-5评分及性交成功率,且不良反应少,值得临床推广。 Objective To assess the curative effects of compound Xuanju capsule combined with Tadalafil the treatment of abdominal obesity with erectile dysfunction( ED) . Methods During the period of August 2016 to January 2017,80 patients with abdominal obesity and ED were selected and divided into two groups ( n=40) . The treatment group was treated with compound Xuanju capsule combined with tadalafil,and the control group was treated with tadalafil alone( n=40) . The pa- tients were reexamined after 4 weeks of treatment. Results IIEF-5 scores and successful intercourse ( SEP-Q3) of two groups were improved variously than before ( P<0.05) . IIEF-5 scores of the treatment group before and after treatment were ( 11.52±2.98) and ( 20.61±1.91) ; IIEF-5 scores of the control group was ( 11.28±3.56) and ( 17.32±2.02) ,and the successful intercourse of two groups were 72.5% and 90.0%. The curative effects of the treatment group was better than that of control group. There were no serious adverse reactions in the two groups. Conclusion The compound Xuanju capsule combined with Tadalafil treatment can effectively improve the IIEF-5 score and sexual intercourse success rate of abdominal obesity patients with ED,with fewer adverse reactions,and is worthy of clinical promotion.
作者 王金国 谭艳 王万荣 谢子平 李韬 谢胜 WANG Jin-guo;TAN Yan;WANG Wan-rong;XIE Zi-ping;LI Tao;XIE Sheng(Depart- ment of Andrology,Renmin Hospital,Hubei University of Medicine,Shiyan,Hubei 442000,China)
出处 《湖北医药学院学报》 CAS 2018年第4期338-340,345,共4页 Journal of Hubei University of Medicine
基金 十堰市科学技术研究与开发项目(17Y37)
关键词 肥胖 勃起功能障碍 他达拉非 复方玄驹胶囊 Obesity Dyslipidemia Compound Xuanju Capsule Tadalafil
  • 引文网络
  • 相关文献

参考文献4

二级参考文献61

共引文献107

同被引文献84

引证文献5

二级引证文献17

相关主题

;
使用帮助 返回顶部